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SUMMARY
The resolution of DNA interstrand crosslinks (ICLs)
requires a complex interplay between several pro-
cesses of DNA metabolism, including the Fanconi
anemia (FA) pathway and homologous recombina-
tion (HR). FANCD2 monoubiquitination and CtIP-
dependent DNA-end resection represent key events
in FA and HR activation, respectively, but very little
is known about their functional relationship. Here,
we show that CtIP physically interacts with both
FANCD2 and ubiquitin and that monoubiquitinated
FANCD2 tethers CtIP to damaged chromatin, which
helps channel DNA double-strand breaks generated
during ICL processing into the HR pathway. Conse-
quently, CtIP mutants defective in FANCD2 binding
fail to associate with damaged chromatin, which
leads to increased levels of nonhomologous end-
joining activity and ICL hypersensitivity. Interest-
ingly, we also observe that CtIP depletion aggravates
the genomic instability in FANCD2-deficient cells.
Thus, our data indicate that FANCD2 primes CtIP-
dependent resection during HR after ICL induction
but that CtIP helps prevent illegitimate recombina-
tion in FA cells.
INTRODUCTION
Fanconi anemia (FA) is a rare hereditary disorder characterized
by bone marrow failure, developmental abnormalities, and can-
cer predisposition (Moldovan and D’Andrea, 2009). Cells iso-
lated from FA patients display chromosomal instability and
hypersensitivity to DNA interstrand crosslink (ICL)-inducing
agents such as mitomycin C (MMC) and cisplatin. The high cyto-
toxicity of MMC, a property exploited in cancer therapy, is pri-
marily based on the strong inhibitory effect of unrepaired ICLs
on DNA replication (Deans andWest, 2011). Recent studies indi-
cate that the FA pathway orchestrates replication-coupled ICL
repair—involving nucleolytic incision, translesion DNA synthesis
(TLS), and homologous recombination (HR)—to maintain
genomic stability (Knipscheer et al., 2009). In response to ICL
damage, the FA core complex, consisting of eight proteins
(FANCA, B, C, E, F, G, L, and M), promotes monoubiquitination
of FANCD2 and FANCI (Garcia-Higuera et al., 2001; Smogor-
zewska et al., 2007). The ubiquitinated FANCD2/I complex reloc-
alizes to damaged chromatin, where it coordinates downstream
repair events (Kim and D’Andrea, 2012). ICL repair is initiated by
nucleolytic incisions on either side of the crosslink and carried
out by SLX4-associated XPF-ERCC1 and MUS81-EME1 nucle-
ases and FAN1 (Kottemann and Smogorzewska, 2013). ICL inci-
sion converts the stalled replication fork into a one-ended DNA
double-strand break (DSB), which is repaired by HR. Interest-
ingly, FA phenotypes can be partially rescued by inhibition of
nonhomologous end-joining (NHEJ), suggesting that the FA
pathway not only promotes error-free HR but also actively sup-
presses inappropriate repair of DSB intermediates by NHEJ in
order to prevent chromosomal instability (Adamo et al., 2010;
Pace et al., 2010).
Although FANCD2 is critically important for ICL repair, its
contribution to HR remains largely elusive (Nakanishi et al.,
2011; Smogorzewska et al., 2007). HR is initiated by DNA-end
resection, which occurs in human cells through the combined
action of CtIP and the MRE11-RAD50-NBS1 (MRN) complex,
together with DNA2 or EXO1 nucleases (Nimonkar et al., 2011;
Sartori et al., 2007). Importantly, DNA-end resection is a key
determinant of DSB repair pathway choice, as it commits cells
to HR, while, at the same time, suppresses NHEJ (Chapman
et al., 2012). A putative connection between the resection ma-
chinery and the FA pathway was recently proposed, based on
data showing that DNA2 and EXO1 depletion leads to cisplatin
hypersensitivity (Karanja et al., 2012). Additionally, CtIP was
shown to accumulate at sites of locally induced ICLs (Duquette
et al., 2012). However, the contribution of DNA-end resection
to ICL repair and the regulation of CtIP by the FA pathway
have not yet been thoroughly investigated.
RESULTS
FANCD2 Is Required for CtIP Localization to ICLDamage
Similar to FA cells, we observed that CtIP depletion results in hy-
persensitivity and increased chromosomal aberrations following
MMC treatment, implicating a key role for CtIP in ICL repair (Fig-
ures 1A, S1A, and S1B). Because FANCD2 monoubiquitination
constitutes a key step of the FA pathway, we investigated
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whether CtIP affects FANCD2 foci formation. However, silencing
of CtIP did not significantly change the assembly of FANCD2 foci
after MMC treatment (Figure 1B). Moreover, FANCD2 monoubi-
quitination and chromatin assembly still efficiently occurred in
CtIP-depleted cells (Figures S1C and S1D). Recently, it was
shown that the knockdown of CtIP leads to a 2-fold reduction
in FANCD2 accumulation at ICLs induced by 8-methoxypsoralen
plus UVA laser microirradiation (PUVA) (Duquette et al., 2012).
Therefore, we subjected CtIP-depleted cells to PUVA treatment
and noticed partially reduced levels of monoubiquitinated
FANCD2 on chromatin (Figures S1E and S1F). Taken together,
our data indicate that CtIP is not strictly required for FANCD2
monoubiquitination in response to ICL-inducing agents but that
its lossmay lead to a negative feedback loop limiting FA pathway
activation during ICL repair.
We also noticed that CtIP was highly enriched on chromatin
upon MMC or PUVA treatment (Figures S1C and S1F). Consis-
tent with this, ICL damage caused a strong increase in CtIP
foci that colocalized with FANCD2 (Figure 1C). Remarkably,
both spontaneous and damage-induced CtIP foci were abro-
gated in FANCD2-depleted cells (Figure 1C). Accordingly,
FANCD2 depletion impaired CtIP chromatin association in
Figure 1. FANCD2 Is Required for the Accumulation of CtIP at Sites of ICL Damage
(A)Metaphase spreads fromHEK293 cells transfectedwith the indicated small interfering RNAs (siRNAs) and treated for 20 hr withMMC (25 ng/ml) were analyzed
for chromosomal aberrations. A total of 100 metaphase spreads from three independent experiments were analyzed for each condition. The percentages of cells
displaying chromatid breaks or radial chromosomes are shown (see also Figure S1B).
(B) After 48 hr of transfection with indicated siRNAs, U2OS cells grown on coverslips were treated for 24 hr with MMC (120 ng/ml), pre-extracted, fixed, and
immunostained for FANCD2. Nuclei were visualized by DAPI-staining. Graph shows the percentage of cells displaying more than ten FANCD2 foci/nuclei.
(C) U2OS cells stably expressing GFP-tagged CtIP were transfected with indicated siRNAs, and 48 hr later, cells grown on coverslips were treated as in (B) and
immunostained for FANCD2. Graph shows the percentage of cells displaying more than ten GFP-CtIP foci/nuclei.
(D and E) U2OS cells were transfected with indicated siRNAs, and 48 hr later, cells were treated as in (B) and extracts were analyzed by immunoblotting.
(F) FANCD2 mutant human fibroblasts (PD20F) and PD20F stably expressing wild-type FANCD2 (WT) or K561R mutant FANCD2 were treated as in (B) and
harvested for immunoblot analysis (see also Figure S1H).
(G) U2OS cells were transfected with FAN1 siRNA and processed as in (D).
In (B) and (C), for each condition, at least 100 cells were scored and the data are presented as the mean ± SD (n = 3). The scale bar represents 5 mm.
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MMC- and PUVA-treated cells (Figures 1D and S1G). In
response to ICL damage, FANCD2 becomes monoubiquitinated
at K561 by the FA core complex (Garcia-Higuera et al., 2001;
Meetei et al., 2003). Depletion of FANCA, a subunit of the FA
core complex, abolished both FANCD2 and CtIP association
with damaged chromatin (Figure 1E). Importantly, impaired
CtIP accumulation at ICLs in FANCD2-deficient fibroblasts
(PD20F) was restored by complementation with wild-type (WT)
FANCD2, but not with the K561R mutant (Figures 1F and S1H).
In addition, CtIP failed to form MMC-induced foci in cells pre-
treated with the proteasome inhibitor MG-132, which leads to
the sequestration of ubiquitin in the cytoplasm, further indicating
that FANCD2 monoubiquitination is a prerequisite for CtIP local-
ization to ICLs (Figure S1I).
During the initial processing of DSBs, CtIP acts together
with the MRE11-RAD50-NBS1 (MRN) complex. We therefore
explored whether efficient localization of CtIP to ICLs may
require theMRNcomplex. However, while NBS1 downregulation
resulted in defective chromatin association of MRE11, the levels
of chromatin-bound FANCD2 and CtIP remained unaltered (Fig-
ure S1J). On the other hand, monoubiquitinated FANCD2 was
reported to directly interact with and recruit FAN1 and SLX4 to
coordinate ICL incision (Kottemann and Smogorzewska, 2013;
Yamamoto et al., 2011). However, depletion of FAN1 or SLX4
did not significantly affect the binding of CtIP to damaged chro-
matin (Figures 1G and S1K). Collectively, our results suggest that
proper localization of CtIP to ICLs is controlled by FANCD2 but
occurs independently of bothMRN and structure-specific nucle-
ases involved in ICL incision.
FANCD2 Facilitates CtIP-Mediated DNA-End Resection
during ICL Repair
We observed that both MMC and PUVA treatment resulted in
robust RPA2-S4/S8 phosphorylation (Figures S2A and S1E).
RPA2 phosphorylation, particularly at S4 and S8, has been
widely used as a surrogate marker for single-stranded DNA
(ssDNA) that is generated by DNA-end resection (Kousholt
et al., 2012). Remarkably, knockdown of CtIP or FANCD2
strongly impaired RPA2 hyperphosphorylation in response to
ICL-inducing agents, which was particularly evident in the chro-
matin-bound fractions (Figures 2A and S2B). Likewise, the per-
centage of cells with RPA2-pS4/S8 foci was significantly
reduced in CtIP- or FANCD2-depleted cells (Figures 2B and
S2C). Moreover, by immunostaining of cells with anti-bromo-
deoxyuridine (anti-BrdU), we found that MMC triggered substan-
tial ssDNA formation, which was reduced upon depletion of CtIP
or FANCD2 (Figures 2C and S2D). Impaired DNA-end resection
commits cells to error-prone repair of DSBs by NHEJ. Recently,
RIF1 was characterized as a key NHEJ-promoting factor by vir-
tue of its role in counteracting resection (Chapman et al., 2013; Di
Virgilio et al., 2013; Escribano-Dı´az et al., 2013; Zimmermann
et al., 2013). Indeed, MMC-induced RIF1 foci were elevated
in CtIP- or FANCD2-depleted cells, further supporting the idea
that both factors promote DNA-end resection and, thus, sup-
press NHEJ during ICL repair (Figures 2D and S2E).
To further substantiate the role of CtIP-dependent resection in
ICL repair, we monitored RIF1 foci in cells expressing GFP-
tagged CtIP-WT, CtIP-T847A, or CtIP-S327A (Figure S2F). The
mutated residues in CtIP represent CDK phosphorylation sites
required for resection (T847A) or for interaction with BRCA1
(S327A) (Figure S2G) (Huertas and Jackson, 2009; Yu and
Figure 2. FANCD2 and CtIP Promote DNA-End Resection during ICL
Repair
(A) U2OS cells were transfected with indicated small interfering RNAs
(siRNAs), and 48 hr after siRNA transfection, cells were either mock-treated
or treated for 24 hr with MMC (120 ng/ml) and extracts were analyzed
by immunoblotting. RPA2 and P-RPA2 represent nonmodified and hyper-
phosphorylated forms of RPA2, respectively.
(B) Same cells as in (A) were grown on coverslips, pre-extracted, fixed, and
coimmunostained for RPA2-pS4/S8 (pRPA2) and RPA2 (see also Figure S2C).
Graph shows the percentage of RPA2-foci-positive cells displaying more than
ten pRPA2 foci.
(C) Same cells as in (A) were coimmunostained for gH2AX and BrdU to visu-
alize single-stranded DNA under nondenaturing conditions (see also Fig-
ure S2D). Graph shows the percentage of gH2AX-foci-positive cells displaying
more than ten BrdU foci.
(D) Same cells as in (A) were immunostained for RIF1 (see also Figure S2E).
Graph shows the percentage of nuclei displaying more than ten RIF1 foci.
(E) U2OS cells were transfected with CtIP siRNA, and 24 hr post-siRNA
transfection, cells were transfected with siRNA-resistant GFP-tagged CtIP
wild-type (WT), T847A, or S327A mutant CtIP (see also Figure S2F). After 48 hr
of siRNA transfection, cells were treated as in (A) and immunostained for RIF1.
Graph shows the percentage of GFP-foci positive cells displaying more than
10 RIF1 foci. The scale bar represents 5 mm.
In (B)–(E), for each condition, at least 100 cells were scored and data are
presented as the mean ± SEM (n = 3).
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Chen, 2004). Our analysis revealed a strong increase in RIF1 foci
in MMC-treated T847A mutant cells, whereas the S327A muta-
tion had no significant impact on RIF1 foci formation (Figure 2E).
In agreement with this result, T847Amutant cells were hypersen-
sitive to MMC, whereas the viability of cells expressing CtIP-
S327A was similar to CtIP-WT cells, further supporting the idea
that BRCA1-CtIP interaction is not required for resection during
ICL repair (Figures S2H and S2I) (Reczek et al., 2013). Thus far,
our findings suggest a pivotal regulatory role for FANCD2 in
priming CtIP-mediated DNA-end resection to prevent aberrant
NHEJ activity following ICL damage.
CtIP Physically Interacts with FANCD2 and Ubiquitin
Given that CtIP localization to sites of ICL damage is facilitated
by FANCD2, we next addressed whether they exist in a complex
and found that FLAG-CtIP efficiently coimmunoprecipitated with
GFP-FANCD2, and vice versa (Figures 3A and S3A). Moreover,
we were able to specifically detect endogenous CtIP coimmuno-
precipitating with FLAG-FANCD2 but did not observe significant
changes in complex formation uponMMC treatment, suggesting
thatmonoubiquitination of FANCD2may not be essential for CtIP
binding (Figure 3B). In order to further address this issue, we
mixed recombinant CtIP purified from insect cells with GFP-
FANCD2 immunoprecipitated from human embryonic kidney
293T (HEK293T) cells. While CtIP efficiently bound to FANCD2-
WT, it only weakly interacted with the FANCD2-K561R mutant,
indicating that FANCD2 and CtIP physically interact and that
complex formationmight be reinforced by FANCD2monoubiqui-
tination (Figures 3C and S3B).
To verify the existence of endogenous CtIP-FANCD2 com-
plexes, we performed proximity ligation assays (in situ PLA). As
shown in Figure 3D, we could readily detect nuclear PLA signals
in undamaged cells, which significantly increased in numbers
upon MMC treatment, indicating that the FANCD2-CtIP interac-
tion is enhanced following ICL damage. Moreover, we observed
a strong reduction in CtIP-FANCD2 complex formation in
FANCA-depleted, but not SLX4- or FAN1-depleted, cells (Figures
3D,S3C, andS3D). These findings further support the importance
of FANCD2 monoubiquitination for the accumulation of CtIP
at damaged chromatin, presumably by facilitating FANCD2-
CtIP interaction. Although sequence analysis revealed that CtIP
does not contain any known ubiquitin-binding motifs (Hofmann,
Figure 3. CtIP Physically Interacts with
FANCD2 and Ubiquitin
(A) HEK293T cells were cotransfected with
FLAG-CtIP along with either empty vector or
GFP-FANCD2, and 48 hr after transfection, cells
were lysed in NP-40 buffer and whole cell ex-
tracts were analyzed before (input) or after
immunoprecipitation (IP) with anti-GFP (see also
Figure S3A).
(B) HEK293T cells were transfected with either
empty vector or FLAG-FANCD2, and 48 hr post-
transfection, cells were either mock-treated or
treated for 24 hr with MMC (120 ng/ml). Cells were
lysed in Triton-X buffer, and whole-cell extracts
were analyzed before (input) or after IP using anti-
FLAG M2 affinity resin.
(C) HEK293T cells were transfected with empty
vector, GFP-FANCD2 (WT), or GFP-FANCD2
K561R (KR). Then 48 hr after transfection, cells
were lysed in NP-40 buffer and whole-cell ex-
tracts were subjected to IP with anti-GFP. After
stringent washings, immunoprecipitated GFP-
tagged proteins were incubated with 0.5 mg of
recombinant FLAG-tagged CtIP (rFLAG-CtIP;
see also Figure S3B). Inputs and recovered
protein complexes were analyzed by immuno-
blotting.
(D) U2OS cells transfected with the indicated
siRNAs were left untreated or treated as in (B).
After pre-extraction, cells were fixed on coverslips
and incubated with antibodies against CtIP and
FANCD2 before the detection of protein-protein
interactions using a fluorescently labeled probe
(PLA-613). Nuclei were visualized by DAPI stain-
ing. Graph shows the quantification of the PLA
signals/nucleus. PLA signals from at least 100 cells were analyzed (n = 3) (see also Figures S3C and S3D). The scale bar represents 5 mm.
(E) His alone () or recombinant His-tagged ubiquitin (rHis-Ub) coupled to nickel nitrilotriacetic acid (Ni-NTA) agarose beads were incubated with HeLa nuclear
extracts (NE). Input and precipitated bead fractions from the pull-downs were subjected to immunoblotting. Ponceau staining is shown to indicate the amounts
of rHis-Ub used in the pull-down assay.
(F) Recombinant FLAG-tagged CtIP was incubated either alone or together with recombinant hemagglutinin (HA)-tagged ubiquitin and the samples were
subjected to IP with anti-HA. Inputs and recovered protein complexes were analyzed by immunoblotting.
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2009), our results prompted us to examine whether CtIP can bind
toubiquitin.As shown inFigure3E,wediscovered thatCtIP is able
to interact with ubiquitin, although less efficiently compared to
Polh that contains a ubiquitin-binding domain (UBD) (Bienko
et al., 2005; Plosky et al., 2006). Furthermore, we observed com-
parable ubiquitin binding abilities of GFP-CtIP and UBZ-domain
containingGFP-SLX4 (Figure S3E) (Yamamoto et al., 2011). How-
ever, while the ubiquitin I44A mutant completely abolished UBZ-
mediated interactions of SLX4 and Polh with ubiquitin, it did not
affect the binding of CtIP, implicating a distinct type of ubiquitin
recognition (Figure S3F). We were also able to detect an interac-
tion between purified, recombinant proteins, implying that CtIP
can directly recognize ubiquitin (Figure 3F). Collectively, these
data demonstrate that CtIP interacts with FANCD2 and that
FANCD2 monoubiquitination enhances FANCD2-CtIP complex
formation, perhaps owing to the ability of CtIP to bind ubiquitin.
FANCD2-CtIP Interaction Promotes Crosslink
Resistance
To establish the functional significance of the FANCD2-CtIP
interaction for ICL repair, we sought to identify the FANCD2-
binding motif in CtIP. Whereas FANCD2 did not bind to a region
of CtIP containing putative coiled-coil motifs (45–160), it bound
efficiently to fragments of CtIP comprising amino acid (aa) resi-
dues 45–298 or 45–371 (Figure 4A), highlighting the region be-
tween aa residues 160–298 of CtIP to be important for FANCD2
binding. Detailed protein sequence analysis of this region re-
vealed four motifs with high sequence conservation between
vertebrates (Figure S4A). Remarkably, cells expressing RRK/
AAA or RYIE/AAIA mutant variants of CtIP were impaired in
MMC-induced GFP-CtIP foci formation and showed increased
RIF1 foci (Figures S4B and S4C). Consistent with a defect in
CtIP foci formation, RRK/AAA and RYIE/AAIA mutants exhibited
reduced FANCD2 binding in glutathione S-transferase (GST)
pull-down experiments (Figures 4B and 4C). Moreover, PLA sig-
nals were reduced in both CtIP mutants after MMC treatment,
further supporting the role of RRK and RYIE motifs in CtIP-
FANCD2 interaction (Figures 4D and 4E). MMC-induced CtIP
foci were also abrogated in U2OS cells stably expressing GFP-
tagged CtIP-RRK/AAA and -RYIE/AAIA mutants, whereas RIF1
foci were significantly increased in those cells (Figure 4F). How-
ever, both CtIP mutants were efficiently recruited to DSB-con-
taining tracks generated by laser microirradiation (Figure S4D).
Underscoring a differential regulation of CtIP in response to
ICL damage, CtIP recruitment to laser-induced DNA lesions
was FANCD2-independent (Figure S4E). Of note, a truncated
CtIP mutant lacking residues 153–322 was still proficient in ubiq-
uitin binding, indicating that neither RRK (aa 177–179) nor RYIE
(aa 185-188) sequence motifs are required for the interaction
between CtIP and ubiquitin (Figures S4F and S4G). Finally,
both RRK/AAA and RYIE/AAIA mutant cells were hypersensitive
to MMC, further supporting the idea that FANCD2 regulates CtIP
functionality during ICL repair (Figure 4G).
CtIP Counteracts ICL-Induced DNA Damage in the
Absence of FANCD2 Activation
To genetically determine the epistatic relationship between
CtIP and FANCD2 in ICL repair, we generated an MRC5 cell
line stably expressing doxycycline (DOX)-inducible small hairpin
RNA (shRNA) against CtIP (Figure 5A). Interestingly, depletion of
FANCD2 in DOX-treated MRC5 cells led to a further increase
in MMC hypersensitivity (Figures 5A and 5B). In agreement
with this, survival of PD20 cells uponMMC treatment was further
reduced after silencing of CtIP (Figure S5A). CtIP/FANCD2-defi-
cient MRC5 cells also showed elevated levels of MMC-induced
RIF1 foci and radial chromosomes compared to cells depleted
for either factor alone, indicative of potent, illegitimate repair of
DSBs by NHEJ (Figures 5C, 5D, S5B, and S5C). Previously,
BRCA1 has been reported to regulate the accumulation of
FANCD2 into repair foci and CtIP recruitment to PUVA-induced
ICLs (Garcia-Higuera et al., 2001; Duquette et al., 2012). Further
supporting a dual, nonredundant role for CtIP in ICL repair,
knockdown of BRCA1 in DOX-treated MRC5shCtIP cells resulted
in increased MMC sensitivity (Figure S5D). Thus, our data sug-
gest that CtIP-dependent DNA-end resection is essential to
counteract the toxic effects of ICL damage when the FA/BRCA
signaling pathway is compromised.
ATR kinase is a major regulator of the FA pathway and pro-
motes FANCD2/I monoubiquitination (Andreassen et al., 2004;
Smogorzewska et al., 2007). Recently, both ATM and ATR
kinases have been implicated in DNA-damage-induced CtIP
phosphorylation (Peterson et al., 2013; Wang et al., 2013). In
order to gain further mechanistic insight into the regulation of
CtIP during ICL repair, we applied selective ATR and/or ATM
inhibitors prior to MMC treatment (Reaper et al., 2011). CtIP
and RPA2 phosphorylation was strongly elevated after ATR
inhibition; meanwhile, FANCD2 monoubiquitination and CHK1
phosphorylation were reduced as expected (Figure 5E, lane 2).
Interestingly, MMC-induced hyperphosphorylation of CtIP and,
to a lesser extent, of RPA2 was reversed when both inhibitors
were combined (Figure 5E, lane 4). These data suggest that
ATM gets hyperactivated when ATR kinase is blocked, probably
as a result of prevalent cleavage of collapsed replication forks
into DSBs. The structure-specific endonuclease MUS81-EME1
has been implicated in the conversion of stalled replication forks
into DSBs, particularly in checkpoint-deficient cells (Hanada
et al., 2006; Murfuni et al., 2013). Indeed, inhibition of ATR
combined with MUS81 depletion significantly reduced the phos-
phorylation of H2AX and KAP1, both established ATM targets,
indicating that MUS81 is at least partially required for the
processing of ICL-stalled forks into DSBs (Figure 5F). Remark-
ably, phosphorylation levels of CtIP were also decreased, further
implying CtIP in promoting DNA-end resection and HR of repli-
cation-associated DSBs in the absence of a fully functional FA
pathway. Taken together, our results demonstrate that during
conventional ICL repair, CtIP-mediated DNA-end resection is
regulated by FANCD2 but that CtIP also helps prevent illegiti-
mate repair of stalled forks in FA-pathway-defective cells.
DISCUSSION
CtIP is an essential factor required for the initiation of DNA-end
resection during HR and, thus, for the suppression of DSB repair
byNHEJ. Given that FA-pathway-deficient cells exhibit increased
chromosomal instability in response to ICL damage, FA pro-
teins have also been implicated in NHEJ inhibition. Indeed, we
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observed that depletionofCtIPor FANCD2 leads to an increase in
radial chromosome formation andRIF1 foci afterMMC treatment,
indicative of enhanced NHEJ activity. Accordingly, DNA-end
resection, as measured by phosphorylated RPA2 and BrdU
focus formation,was reduced inCtIP- or FANCD2-depleted cells.
Several mechanisms have been proposed how FA proteins pre-
vent NHEJ, including the restriction of NHEJ factors to access
DNA termini, cryptic exonuclease, or nucleosome-assembly
activity of FANCD2 (Adamo et al., 2010; Pace et al., 2010; Sato
et al., 2012). Based on our data, we propose that FANCD2 sup-
presses error-prone NHEJ through promoting CtIP-dependent
resection (Figure S6).
We observed that monoubiquitinated FANCD2 tethers CtIP to
damaged chromatin and identified two short, highly conserved
motifs within CtIP responsible for CtIP-FANCD2 interaction.
Consequently, CtIP mutants defective in FANCD2 binding are
Figure 4. Functional Characterization of CtIP Mutants Impaired in FANCD2 Binding
(A) GST or GST-CtIP proteins were coupled to glutathione Sepharose beads and incubated with HEK293T cell lysates transiently overexpressing GFP-FANCD2.
The recovered materials were analyzed by immunoblotting.
(B) Alignment of the putative FANCD2-interacting region in CtIP orthologs. RRK and RYxE motifs are highlighted in black boxes. Other, highly conserved amino
acid residues are marked in bold typeface (see also Figure S4A).
(C) GST or indicated GST-CtIP (45–298) proteins were coupled to glutathione Sepharose beads and incubated with HEK293T cell lysates transiently over-
expressing GFP-FANCD2. The recovered materials were analyzed by immunoblotting.
(D) U2OS cells stably expressing siRNA-resistant GFP-tagged wild-type (WT) and mutant (RRK/AAA and RYIE/AAIA) CtIP were transfected with CtIP siRNA for
72 hr, and whole-cell extracts were analyzed by immunoblotting. (S) and (L) indicate short and long exposures of the same immunoblot, respectively.
(E) Same cells as in (D) were transfected with CtIP siRNA. After 48 hr of siRNA transfection, cells grown on coverslips were treated for 24 hr withMMC (120 ng/ml),
fixed, and incubated with antibodies against CtIP and FANCD2 before the detection of protein-protein interactions using a fluorescently labeled probe (PLA-613).
Graph shows the quantification of the PLA signals/nucleus in GFP-positive cells. PLA signals from at least 100 cells were analyzed (n = 2).
(F) Same cells as in (E) were fixed and immunostained for RIF1. Graphs show the percentage of GFP-positive cells displayingmore than tenGFP-CtIP foci or more
than ten RIF1 foci, respectively. For each condition, at least 100 cells were scored. Data are presented as the mean ± SEM (n = 2).
(G) Same cells as in (D) were either mock-treated or continuously treated with the indicated doses of MMC, and the survival was determined after 5 days using the
CellTiter-Blue cell viability assay. Data are presented as the mean ± SD (n = 3).
In (E) and (F), the scale bar represents 5 mm.
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impaired in the formation of MMC-induced foci. Whereas
FANCD2monoubiquitinationmaynot beessential for thephysical
interactionwithCtIP, it is required to retainCtIPondamagedchro-
matin.Remarkably,weshow thatCtIPdirectly interactswith ubiq-
uitin in vitro. Although bioinformatic analysis failed to predict
any motifs resembling known UBDs in CtIP, it is plausible that
the FANCD2-CtIP interaction is reinforced by the ability of CtIP
to recognize ubiquitin. However, a CtIP mutant lacking both
FANCD2-interacting motifs was proficient in ubiquitin binding.
Furthermore, a mutant form of ubiquitin (I44A) defective in most
UBD-mediated interactions was still able to interact with CtIP.
Therefore, one could hypothesize that CtIP may employ a dual
modeof recognizingmonoubiquitinatedFANCD2,but, if so, binds
ubiquitin by a uniquemechanism that involves a new type of UBD
(Bomar et al., 2007). Clearly, further investigations are needed to
establish the role of CtIP-ubiquitin interaction in the DNA damage
response. On the other hand, it was proposed that monoubiquiti-
nation of FANCD2 could alter FANCD2 conformation (Joo et al.,
2011). Thus, it is tempting to speculate that such structural
changes in FANCD2 stimulate CtIP-FANCD2 interaction. Finally,
the FANCD2/I complex may also facilitate CtIP recruitment
to damaged chromatin via its histone chaperone activity (Sato
et al., 2012). Increased MMC-induced sensitivity and RIF1 foci
formation in cells expressing CtIP mutants (RRK/AAA and RYIE/
AAIA) further strengthen thesignificanceofCtIP-FANCD2 interac-
tion in ICL repair. Notably, R177Q and Y186C, two cancer-asso-
ciated missense mutations in human CtIP, map exactly to the
region implicated in FANCD2 interaction (Figure S4A). Given
that RRK and RYIE motifs reside in a highly conserved stretch of
12 amino acids, it is also reasonable to think that they constitute
a single FANCD2 interaction ‘‘domain.’’ These data are similar
to those described in the accompanying paper by Unno et al.
(2014) published in this issue of Cell Reports.
Depletion of CtIP in FANCD2-deficient cells aggravates the
phenotypes of cells lacking either factor alone, indicating that
CtIP contributes to genome stability in FA-pathway-defective
Figure 5. CtIP Contributes to Genome Stability in FA-Pathway-Deficient Cells
(A) MRC5 cells stably expressing doxycycline (DOX)-inducible shRNA against CtIP (MRC5shCtIP) were transfected with indicated siRNAs. Then 24 hr after siRNA
transfection, cells were cultivated in the absence or presence of DOX (1 mg/ml) for 48 hr. Cells were treated with MMC (120 ng/ml) for 24 hr and subjected to
immunoblotting.
(B) Same cells as in (A) were treated for 24 hr with indicated doses of MMC, and survival was determined after 10 days by colony-formation assay. Data are
presented as the mean ± SD (n = 3).
(C) Same cells as in (A) were immunostained for RIF1. Graph shows the percentage of RIF1-foci-positive cells displaying more than ten RIF1 foci. For each
condition, at least 100 cells were scored. Data are presented as the mean ± SD (n = 3) (see also Figure S5B).
(D) Metaphase spreads from the same cells as in (A) treated for 20 hr with MMC (20 ng/ml) were analyzed for chromosomal aberrations. A total of 45 metaphase
spreads from three independent experiments were analyzed for each condition. The percentages of cells displaying radial chromosomes are shown (see also
Figure S5C).
(E) U2OS cells were pretreated for 15 min with DMSO, ATR inhibitor (VE-821, 1 mM), ATM inhibitor (KU-55933, 10 mM), or both inhibitors together. Cells were then
treated for 20 hr with MMC (120 ng/ml), and extracts were analyzed by immunoblotting.
(F) U2OS cells were transfected with MUS81 siRNA, and 48 hr after siRNA transfection, cells were pretreated for 15 min with DMSO or ATR inhibitor (VE-821,
1 mM). Cells were then treated as in (E) and harvested for immunoblot analysis.
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cells. Likewise, inactivation of FAN1 or SLX4 enhanced crosslink
sensitivity of cells compromised in FANCD2 activation, suggest-
ing that these proteins, though being recruited to ICLs by
FANCD2, can promote MMC resistance in a FA-pathway-inde-
pendent manner (Yamamoto et al., 2011; Zhou et al., 2012).
Furthermore, only partial epistasis of FANCD2 over CtIP could
be explained by an additional role of CtIP upstream of FANCD2
or by the proposed role of FANCD2 in protecting stalled forks
from degradation (Duquette et al., 2012; Schlacher et al.,
2012). There is increasing evidence that arrested and unpro-
tected replication forks frequently collapse and give rise to
DSBs, which can then undergo resection and repair by HR
(Couch et al., 2013). Accordingly, we observed enhanced
ATM-dependent phosphorylation of CtIP and RPA2 in cells co-
treated with MMC and ATR inhibitor, indicative of ongoing DSB
resection (Fugger et al., 2013). In line with this, CtIP phosphory-
lation was reduced upon depletion of MUS81, an endonuclease
implicated in the cleavage of stalled forks and DSB formation
(Ciccia et al., 2008). Furthermore, CtIP-dependent processing
of collapsed forks upon hydroxyurea treatment was recently re-
ported to be beneficial for genome integrity in the absence of
FANCM (Blackford et al., 2012). Therefore, we conclude that
CtIP can partially suppress genomic instability in the absence
of FANCD2, whereas, in FA-pathway-proficient cells, monoubi-
quitinated FANCD2 coordinates CtIP-mediated DNA-end resec-
tion during ICL repair.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
U2OS, HEK293T, and HEK293 cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal calf serum (FCS),
100 U/ml penicillin, and 100 mg/ml streptomycin. U2OS clones stably express-
ing siRNA-resistant forms of GFP-CtIP were described previously (Sartori
et al., 2007). FANCD2-deficient cells (PD20F) were obtained from Fanconi
Anemia Research Foundation (FARF) and cultured in DMEM supplemented
with 10% FCS and standard antibiotics. PD20F cells complemented with
FANCD2 wild-type (FARF) or K561R (kindly provided by Josef Jiricny) were
grown in standardmedium supplementedwith 1 mg/ml Puromycin.MRC5shCtIP
cells were grown in DMEM supplemented with 10% Tet system approved
FCS, 100 U/ml penicillin, 100 mg/ml streptomycin, Blasticidin (5 mg/ml), and
Zeocin (250 mg/ml). Plasmids were transfected either by using the standard
calcium phosphate method or FuGENE 6 (Roche) according tomanufacturer’s
instructions. Transfection of all siRNA oligos was done with 40 nM final con-
centration using Lipofectamine RNAiMAX (Invitrogen). Data for survival curves
were generated by colony-formation assays as described previously (Sartori
et al., 2007).
Triton Extraction
Isolation of Triton-insoluble (chromatin-enriched) fractionwasperformedaspre-
viously described (Pen˜a-Diaz et al., 2012). In brief, cellswere rinsed twice in cold
PBS and incubated for 5 min on ice in preextraction buffer (25 mM HEPES
[pH 7.4], 50 mMNaCl, 1 mMEDTA, 3 mMMgCl2, 300mM sucrose, 0.5% Triton
X-100, and protease inhibitors). After buffer removal, adherent cellular material
washarvestedbyscraping thecells intoLaemmlibuffer.Thechromatin-enriched
fraction was then heat denatured, sonicated, and analyzed by immunoblotting.
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